US-based radiation therapy company Accuray has received China’s National Medical Products Administration (NMPA) approval for its Accuray Precision Treatment Planning System (TPS).
The Accuray Precision TPS is designed to enable the creation and adaptation of precise treatment plans in a short time.
It is intended for use in combination with the CNNC-Accuray joint venture Tomo C radiation therapy system.
The system will provide medical care teams with a new option to deliver precise and accurate radiotherapy treatments, expanding access to care for more cancer patients in China.
It enables clinicians to routinely incorporate modifications to treatment planning into the course of treatment as per the changes in tumour size, shape, and location.
In addition, the system supports subtle changes in the location of organs and other healthy tissue, to enhance the treatment precision.
Accuray president and CEO Suzanne Winter said: “We couldn’t be more pleased about the approval of the Accuray Precision Treatment Planning System and the potential it represents, in combination with the Tomo C System, for cancer patients in China, a country which accounted for approximately 25% of new cancer cases diagnosed worldwide in 20201.
With this approval our China joint venture can begin shipping the Tomo C System to their end customers, an important step forward in helping to address an unmet need for precision radiation therapy.”
The Tomo C platform features helical imaging and radiation delivery, with fully integrated treatment planning, centralized data management and ultra-precise treatment delivery.
It leverages patented beam-shaping technology, to provide superior control of the radiation dose to conform precisely to the tumour and help minimise dose to healthy tissue.
The system is designed to enable medical care teams to optimise outcomes for standard radiation therapy indications, along with complex treatments.
Winter added: “Customers in China who use our organization’s CyberKnife, Radixact and TomoTherapy Systems are familiar with the Accuray Precision Treatment Planning System, a powerful, full-featured system that enables clinicians to efficiently generate high-quality radiation therapy treatment plans.
“The availability of the treatment planning solution for the Tomo C System, a domestic made radiation therapy delivery device, will expand our portfolio in China and enhance our access in the regional Type B market.”
